Lower degree of susceptibility to ibalizumab for 9 of 10 patients with virology failure, rebound.
Intervention group had greater reduction in condomless sex acts vs standard of care group.
The International Antiviral Society-USA Panel has updated its recommendations for the management and prevention of HIV infection, to reflect the most current data on new treatment regimens and strategies.
Close to one-third of sexually active HIV-positive men who have sex with men (MSM) have not received syphilis screening in the past 12 months.
Findings among teens diagnosed with pelvic inflammatory disease in the emergency department.
ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis.
Investigators added hepatitis C virus and HIV screening tests to standard trauma activation laboratory orders.
Vaccinated women and girls living with HIV may be at greater risk for HPV vaccine failure compared with women and girls without HIV.
Single high-dose liposomal amphotericin B (L-AmB) is non-inferior to daily dosed L-AmB at the standard dose in treatment of fungal clearance in HIV-associated cryptococcal meningitis.
Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.
No increased risk of depression or suicidal ideation among persons living with HIV in Uganda.
Annual occasion is a good time for health care providers to encourage testing
The Agency has received reports of serious neural tube birth defects involving the brain, spine, and spinal cord in babies born to women who received dolutegravir for HIV treatment.
The FDA has approved Trogarzo for heavily treated adult patients living with HIV and whose HIV infections cannot be successfully treated with other currently available therapies.
CVS Health faces lawsuit for revealing the HIV status of 6,000 patients in Ohio.
The two most prevalent HIV symptoms, fatigue and muscle aches, are more common in women than men and can worsen with menopause.
Recommendations for daily doses of emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) resulted in protective drug concentrations for men and transgender women.
A new antiretroviral HIV treatment, Trogarzo (ibalizumab-uiyk), has been approved by the FDA for patients with HIV who have not have success with past HIV medications.
Increasing awareness of and access to newer HIV testing options such as free or reduced price on home and self-tests and couples HIV testing and counseling can facilitate increased levels of consistent testing among young, Black MSM, and transgender women.
Bacterial vaginosis may cause an increased risk for HIV acquisition in women taking oral or injectable hormonal contraception.
Excessive alcohol consumption does not impact the decline of CD4 cell count in patients with HIV who have not undergone antiretroviral treatments.
Chronicity of depression is associated with increased likelihood of failure along the continuum of HIV care.
For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective.
One third of HIV patients in the United States remain unvaccinated against hepatitis B.
Post-seroconversion brain morphology can occur in HIV patients, but aviremia maintenance via cART can slow of prevent brain injuries.
A new report from the CDC finds that HIV is being diagnosed sooner after initial infection than in previous years.
Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir.
The decrease in HIV incidence in Uganda was facilitated by antiretroviral therapy, male circumcision, and adolescent abstinence.
More tests might be administered to transgender individuals who are female, black, or sex workers.
The dual combination of dolutegravir plus darunavir/ritonavir provided a simple and safe salvage therapy to suppress viral replication without metabolic impact in patients infected with HIV-1.